Medications to Avoid in Porphyria

Medications to Avoid in Porphyria
0
(0)

Everyone needs to take some form of medication at some point. People with porphyria, however, need to be extra careful about which medications they take.

Porphyria is a group of rare genetic disorders that lead to problems with the synthesis of a protein called heme, which is an integral part of many other proteins in the body. The most widely known of these, hemoglobin, is necessary for oxygen to be carried in red blood cells.

Can medications cause attacks?

Patients with one of the acute porphyrias, including acute intermittent porphyria (AIP), variegate porphyria (VP), hereditary coproporphyria (HCP), and ALA dehydratase deficiency porphyria, should be careful when taking certain medications. This is because they can cause painful and potentially life-threatening attacks.

Several types of medications may induce these attacks. These include, but are not limited to, certain anesthetics, antihistamines, antiepileptics, antihyperglycemics (like those used to treat diabetes), some antibiotics, and some heart medicines.

Sex hormone treatments for women, such as implanted or injected contraceptives, can also cause acute porphyria attacks. Oral contraceptives that contain estrogen may also contribute to porphyria cutanea tarda.

How can medications cause an attack?

The body uses cytochrome P450 enzymes (CYP450) to break down many medications. Heme is necessary to produce CYP450. Low heme levels lead to the liver producing a precursor of heme called delta-aminolevulinic acid (ALA).

Patients with porphyria are deficient in enzymes that are active in different places along the pathway to convert ALA into heme. Depending on which enzyme is deficient, patients will have different symptoms. Since the heme synthesis pathway ends up with a roadblock along the way, porphyrins and porphyrin precursors accumulate inside cells to cause porphyria.

What precautions should be taken?

Doctors should investigate a medication’s “porphyrinogenic” history, or whether it has caused acute attacks in patients with porphyria in the past. The Norwegian Porphyria Centre (NAPOS) has a database of medications with a classification system to assist physicians in deciding how porphyrinogenic a certain medication may be.

However, it can  be very hard to predict an individual’s reaction to a certain medication, as there are multiple factors that can influence this. People with porphyria should, therefore, avoid medications as much as possible, including recreational drugs such as cannabis. Alcohol consumption and cigarette smoking (nicotine use) should be limited.

If absolutely necessary, patients should use the medications with the shortest course in case of an attack. Longer-acting medications can be problematic, as their effects can cause symptoms to continue and possibly increase in intensity.

People with porphyria should avoid combination medications.

 

Last updated: Sept. 30, 2020

***

Porphyria News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Brian holds a Ph.D. in Biomedical Engineering from Case Western Reserve University and a Bachelors of Science in Biomedical Engineering from Georgia Institute of Technology. He has co-authored numerous scientific articles based on his previous research in the field of brain-computer interfaces and functional electrical stimulation. He is also passionate about making scientific advances easily accessible to the public.
Total Posts: 0
Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
×
Brian holds a Ph.D. in Biomedical Engineering from Case Western Reserve University and a Bachelors of Science in Biomedical Engineering from Georgia Institute of Technology. He has co-authored numerous scientific articles based on his previous research in the field of brain-computer interfaces and functional electrical stimulation. He is also passionate about making scientific advances easily accessible to the public.
Latest Posts
  • porphyria in children
  • Reproductive Options
  • medications
  • anesthesia

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *